Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Factors Predicting Biochemical Response and Survival Benefits Following Radioligand Therapy With [177Lu]Lu-Psma in Metastatic Castrate-Resistant Prostate Cancer: A Review
Nasim Vahidfar
Nasim Vahidfar

Assistant Professor of Nuclear Pharmacy

Department Nuclear Medicine

School of Medicine

Tehran University of Medical Sciences

Related Documents
1. Historical Review of Pharmacological Development and Dosimetry of Psma-Based Theranostics for Prostate Cancer, Journal of Radioanalytical and Nuclear Chemistry (2019)
All Documents
1. [68Ga]Ga-Α-Msh As a Pet Radiotracer for Detection of Metastatic Melanomas: A Preliminary Study, Journal of Radioanalytical and Nuclear Chemistry (2025)
2. A Ct-Free Deep-Learning-Based Attenuation and Scatter Correction for Copper-64 Pet in Different Time-Point Scans, Radiological Physics and Technology (2025)
3. A Review of Psma-Based Radiopharmaceuticals for Diagnosis and Therapy of Prostate Cancer, Journal of Radioanalytical and Nuclear Chemistry (2025)
4. Comparison of Diagnostic Performance of [68Ga]-Ga-Fapi-46 and [18F]-Fdg Pet/Ct Imaging for the Detection of Lesions and Disease Staging in Patients With Breast Cancer, Asia Oceania Journal of Nuclear Medicine and Biology (2025)
5. Evaluation of Diagnostic Value of [67Ga]Ga-Phytate in Detection of Axillary Lymph Nodes in Breast Cancer Patients, Journal of Radioanalytical and Nuclear Chemistry (2025)
6. First-In-Human Dosimetry and Safety Evaluation of 68Ga-Αmsh Derivative for Pet Imaging of Melanoma, Scientific Reports (2025)
7. Imaging Properties of [18F]Fdg-Wbc Pet/Ct Scan in Detection of Infection: Benefits and Drawbacks”, Journal of Radioanalytical and Nuclear Chemistry (2025)
8. Recent Advances in the Diagnosis of Alzheimer's Disease: A Brief Overview of Tau Pet Tracers in Nuclear Medicine, Current Radiopharmaceuticals (2025)
9. A Brief Overview of Common Radiopharmaceuticals for Detection of Infection/Inflammation in Nuclear Medicine, Journal of Radioanalytical and Nuclear Chemistry (2024)
10. Impact of Attenuation Correction, Collimator, and Iterative Reconstruction Protocols On67ga Spect/Ct Quantification, Frontiers in Biomedical Technologies (2024)
11. Optimal Indications of Radioimmunotherapy in Nuclear Medicine: A Mini-Review, Current Radiopharmaceuticals (2024)
12. Radiopharmaceuticals for Sentinel Lymph Node Identification in Breast Cancer, Journal of Radioanalytical and Nuclear Chemistry (2023)
13. Recent Trends in Diagnostic Biomarkers of Tumor Microenvironment, Molecular Imaging and Biology (2023)
14. A Multi-Step Centrifuge Method for Extraction of Leucocytes and Preparation of Tc-Hmpao Labeled Leucocytes, Tehran University Medical Journal (2022)
15. A Review of Nuclear Medicine Approaches in the Diagnosis and the Treatment of Gynecological Malignancies, Cancers (2022)
16. Diagnostic Value of Radiolabelled Somatostatin Analogues for Neuroendocrine Tumour Diagnosis: The Benefits and Drawbacks of [64Cu]Cu-Dota-Toc, Cancers (2022)
17. Preparation and Validation of [67Ga]Ga-Phytate Kit and Monte Carlo Dosimetry: An Effort Toward Developing an Impressive Lymphoscintigraphy Tracer, Journal of Radioanalytical and Nuclear Chemistry (2022)
18. 177Lu-Edtmp for Metastatic Bone Pain Palliation: A Systematic Review and Meta-Analysis, Cancer Biotherapy and Radiopharmaceuticals (2021)
19. An Impressive Approach in Nuclear Medicine: Theranostics, PET Clinics (2021)
20. Discordance Between Using Estimated and Measured Glomerular Filtration Rate for Drug Dosing in Kidney Transplant Recipients, Iranian Journal of Kidney Diseases (2021)
21. Mucin-1 Conjugated Polyamidoamine-Based Nanoparticles for Image-Guided Delivery of Gefitinib to Breast Cancer, International Journal of Biological Macromolecules (2021)
22. Theranostic Advances in Breast Cancer in Nuclear Medicine, International Journal of Molecular Sciences (2021)
23. Historical Review of Pharmacological Development and Dosimetry of Psma-Based Theranostics for Prostate Cancer, Journal of Radioanalytical and Nuclear Chemistry (2019)
24. Preparation of a 153Sm-5,10,15,20-Tetrakis(4-Methoxyphenyl) Porphyrin Complex As a Possible Therapeutic Agent, Iranian Journal of Nuclear Medicine (2015)